Don't expect Miracle Treatments
The Royal Society of Chemistry’s online edition of Chemistry World today announced the partnership between scientists at the University of California-Los Angeles (UCLA) and the private investment firm NanoPacific Holdings; the partnership will develop and market 'nanomachines' to treat cancer, explaining that ‘the first treatments could be ready for clinical trials in as little as three years’.
Andrew Maynard, chief science adviser at the US-based Project on Emerging Nanotechnologies (PEN), said that the partnership was a sign that nanotechnology is 'coming of age'.
On the other hand Steffi Friedrichs, director of the Nanotechnology Industries Association, warned that 'it would be wrong to expect the overnight rise of miracle treatments'.
Follow this link to read the full story.